ABSTRACT
[This corrects the article DOI: 10.7759/cureus.50541.].
ABSTRACT
Helicobacter pylori has been reported as a health problem worldwide, affecting a sizable portion of people. Peptic ulcers, gastric cancer, and various extra gastric conditions are associated with this bacterium. The rampant overprescribing of antibiotics has led to the emergence of H. pylori strains resistant to multiple antibiotics, causing a decline in the effectiveness of current treatments. Recently, there has been growing interest in researching alternative treatment options for H. pylori infections that do not respond to initial therapy. Rifabutin, a rifamycin derivative initially designed for tuberculosis treatment and preventing Mycobacterium avium complex infection, has gained attention as a potential rescue medication. It has shown efficacy against H. pylori and the potential to eradicate the bacterium when combined with other antibiotics. This systematic review article focuses on using rifabutin-based regimens as a treatment option after initial treatments have failed. The authors screened literature published in the last five years, between 2017 and 2022, across various search engines and closely examined relevant studies following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. The search covered a variety of electronic databases and focused on H. pylori gastritis, rifabutin-based treatment plans, and in vivo investigations in healthy individuals. The comprehensive review provides convincing evidence that rifabutin-based regimens are effective rescue treatments for H. pylori infections. Multiple studies in various areas consistently demonstrated high eradication rates, ranging from 70% to 90%, when rifabutin-containing regimens were used. The analysis found that only a tiny percentage of H. pylori strains (1%) were resistant to rifabutin therapy, further supporting the viability of Rifabutin as an alternative when other antibiotics failed to eradicate H. pylori. The cost of Rifabutin is a significant factor that may limit its accessibility, particularly in resource-constrained settings where H. pylori infection is common. Moreover, the potential side effects of Rifabutin, such as hematological problems, rashes, and digestive issues, need to be considered. However, these side effects are typically manageable and can be reduced by combining Rifabutin with other antibiotics. In conclusion, this systematic review provides evidence supporting the effectiveness of regimens derived from Rifabutin in eliminating H. pylori infections after initial therapy failure. Due to the observation that Rifabutin effectively eradicates resistant H. pylori infections, it can be considered a suitable choice for rescue therapy. Rifabutin-containing regimens should be reserved as fourth- or later-line therapy options, considering economic factors, the risk of microbial resistance, potential side effects, and the availability of alternative medications. Future research should focus on optimizing rifabutin-based regimens and investigating combination therapies that have better H. pylori eradication rates while also addressing the problem of resistant strains.
ABSTRACT
Cosmetic foundation creams are encountered as evidentiary material in criminal investigations, particularly in cases related to sexual and physical assault against women. Analyzing foundation cream exhibit is a challenging task as the exhibit is recovered in trace quantity with similar hue. In the present study, ATR FTIR spectroscopy which is a rapid, nondestructive, sensitive, reliable, and safe alternative to other analytical techniques has been used to differentiate 31 cosmetic foundation creams belonging to 23 different brands supported by chemometric methods such as principal component analysis (PCA) and linear discriminant analysis (LDA). The discriminating power of visual analysis is found to be 98.0%, while PCA and LDA further increased the discriminating power to 99.3% and 100%, respectively. The blind test is conducted with three unknown samples (pretended to be unknown to the analyst), which were correctly linked with their respective source. Further, the effect of substrate such as tissue paper (dry and wet) and white cotton cloth during sample analysis are also examined to simulate the actual forensic casework conditions. The stains on substrates could be identified and linked to its parent product as well. The reported method provides significant results for the differentiation of cosmetic foundation creams.
